Florastor

Biocodex is a family-owned French pharmaceutical company founded in 1953, best known for its flagship probiotic brand, Florastor. The company specializes in the development and manufacturing of Saccharomyces boulardii lyo CNCM I-745, the first probiotic yeast discovered for human use. Biocodex focuses on microbiota health, orphan diseases, and neurology, operating globally with a presence in over 100 countries. Their product portfolio includes treatments for gastrointestinal disorders and rare forms of pediatric epilepsy. The company maintains a strong commitment to scientific research through the Biocodex Microbiota Foundation, which supports academic studies on the human microbiome.